Vitality Watch

Dossier pubmed review 06-jul-2026
Narrative review or expert overview without new data

From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.

Key claim: Organ age gaps from multi-omic, imaging, and digital data can localize apparent aging burden for precision geromedicine, but circulating signals rarely prove tissue origin and cross-organ coupling should be treated as graded inference, not direct propagation, without stronger longitudinal or experimental support.

Abstract

Biological aging is increasingly understood as a heterogeneous, multi-system process marked by organ-level vulnerability, cross-organ coordination, and variation in resilience. Advances in plasma proteomics, metabolomics, imaging, DNA methylation, digital biomarkers, and genetic epidemiology have enabled organ-level, system-level, and cross-organ age models, but these measures are often interpreted more strongly than the evidence permits. In this Review, we synthesize evidence on biological age models derived from molecular, imaging, digital, clinical, and multi-omic data and introduce ORGAN-AGE as an interpretive framework for judging what these signals can and cannot establish. We distinguish organ-derived, organ-enriched, organ-informative, system-informative, and systemic biomarkers, because circulating molecular signals rarely prove tissue origin. We critically evaluate how age gaps are constructed, bias-corrected, validated, interpreted, and linked to mortality, frailty, dementia, cardiovascular disease, diabetes complications, multimorbidity, and functional decline. A central argument is that organ age gaps can localize apparent aging burden, whereas cross-organ coupling should be treated as a graded inference rather than evidence of direct biological propagation unless longitudinal, molecular, genetic, functional, or experimental support is available. Resilience should likewise be operationalized through recovery, adaptation, and trajectory change rather than inferred from static biomarkers alone. Finally, we outline a staged translational roadmap in which organ aging models may support risk interpretation, trial enrichment, target prioritization, and future digital-twin research only after calibration, transportability, incremental utility, and clinical end-use have been demonstrated.

Why this matters

Organ-specific biological age clocks are the current frontier framing in longevity clinics and biohacker media — sold as pinpointing ‘which organ is aging fastest.’ This review tracks that frame while making the gap explicit: circulating signals usually can’t prove a tissue of origin, and cross-organ links are inference, not demonstrated propagation. For a consumer-protection vault, the divergence between how organ-age reports are marketed and what the underlying signals actually support is itself the story.

Source

Link

Briefing card

From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.
Stage: review · pubmed · 06-jul-2026

If you see an organ-specific biological age score in a consumer or clinical report, this review argues the number localizes a statistical signal, not necessarily aging in that organ.

Organ age gaps from multi-omic, imaging, and digital data can localize apparent aging burden for precision geromedicine, but circulating signals rarely prove tissue origin and cross-organ coupling should be treated as graded inference, not direct propagation, without stronger longitudinal or experimental support.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103238

build build 880 · 2bcef25 · 2026-11-18